e-learning
resources
ERJ
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled corticosteroids in COPD: the final verdict is…
Janice M. Leung, Don D. Sin
Source:
Eur Respir J, 52 (6) 1801940; 10.1183/13993003.01940-2018
Journal Issue:
December
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Janice M. Leung, Don D. Sin. Inhaled corticosteroids in COPD: the final verdict is…. Eur Respir J, 52 (6) 1801940; 10.1183/13993003.01940-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Inhaled corticosteroids in COPD: the case against
Source: Eur Respir J 2009; 34: 13-16
Year: 2009
Inhaled corticosteroids in COPD: a case in favour
Source: Eur Respir J 2009; 34: 10-12
Year: 2009
Inhaled corticosteroids in COPD: the clinical evidence
Source: Eur Respir J 2015; 45: 525-537
Year: 2015
Inhaled corticosteroids: a controversial add-on treatment in COPD
Source: Eur Respir J 2010; 36: 973-974
Year: 2010
Inhaled beta2-agonists in asthma management: an evolving story
Source: Breathe 2016; 12: 375-377
Year: 2016
What to use INSTEAD of inhaled corticosteroids in COPD?
Source: Eur Respir J 2014; 44: 1391-1393
Year: 2014
Inhaled steroids and COPD
Source: Eur Respir J 2008; 32: 523-524
Year: 2008
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022
Year: 2022
Treatment with inhaled corticosteroids (ICS) in patients with COPD: possible way of optimisation
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Inhaled corticosteroids as a cause of CAP
Source: Eur Respir Monogr 2014; 63: 234-242
Year: 2014
Inhaled steroids in exacerbations of COPD
Source: Eur Respir J 2007; 30: 398
Year: 2007
Inhaled corticosteroid containing combinations and mortality in COPD
Source: Eur Respir J, 52 (6) 1801230; 10.1183/13993003.01230-2018
Year: 2018
Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
Knowing when to stop: inhaled corticosteroids and COPD
Source: Eur Respir J 2015; 46: 1236-1238
Year: 2015
Inhaled corticosteroids in treatment of patients with intermittent bronchial asthma: yes or no?
Source: Eur Respir J 2005; 26: Suppl. 49, 503s
Year: 2005
Inhaled corticosteroids and FEV1 decline in asthma: an international cohort study
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Year: 2018
Weaning from inhaled corticosteroids in COPD: the evidence
Source: Eur Respir J 2015; 46: 1232-1235
Year: 2015
Inhaled steroids prescribing in patients with COPD in the community
Source: Eur Respir J 2001; 18: Suppl. 33, 59s
Year: 2001
Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept